Hospice Of Mercy-durango 175 Mercado Street, Suite 131, Durango, CO, 81301 | |
(970) 382-2000 |
News Archive
Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.
With identity theft complaints reaching a 5-year high, and the cost to consumers increasing, the longer the fraud goes undetected, according to Javelin Strategy & Research, the urgency to guard against this crime has increased as well.
A team of scientists from I.M. Sechenov First Moscow State Medical University together with their colleagues isolated a peptide named emericellipsin A from soil fungi.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
› Verified 8 days ago
Name | Hospice Of Mercy-durango |
---|---|
Location | 175 Mercado Street, Suite 131, Durango, Colorado |
Hospice ID | 061512 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 330 |
News Archive
Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.
With identity theft complaints reaching a 5-year high, and the cost to consumers increasing, the longer the fraud goes undetected, according to Javelin Strategy & Research, the urgency to guard against this crime has increased as well.
A team of scientists from I.M. Sechenov First Moscow State Medical University together with their colleagues isolated a peptide named emericellipsin A from soil fungi.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
› Verified 8 days ago
NPI Number | 1164522108 |
Organization Name | Catholic Health Initiatives Colorado |
Address | 1970 East Third Avenue #100 Durango, Colorado, 81301 |
Phone Number | (970)382-2000 |
News Archive
Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.
With identity theft complaints reaching a 5-year high, and the cost to consumers increasing, the longer the fraud goes undetected, according to Javelin Strategy & Research, the urgency to guard against this crime has increased as well.
A team of scientists from I.M. Sechenov First Moscow State Medical University together with their colleagues isolated a peptide named emericellipsin A from soil fungi.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.1 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 96.6 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 88.8 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 77.4 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 96.1 | 97.3 |
Patients who got timely treatment for shortness of breath | 94.7 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 97.8 | 93.3 |
News Archive
Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.
With identity theft complaints reaching a 5-year high, and the cost to consumers increasing, the longer the fraud goes undetected, according to Javelin Strategy & Research, the urgency to guard against this crime has increased as well.
A team of scientists from I.M. Sechenov First Moscow State Medical University together with their colleagues isolated a peptide named emericellipsin A from soil fungi.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
› Verified 8 days ago
Home Health Aides | 1.5 |
Counselors | 1.2 |
Medical Social Workers | 0.6 |
Physicians | 1 |
Registered Nurses | 2.7 |
Other Personnel | 2.42 |
Total Employees | 9.42 |
---|
News Archive
Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.
With identity theft complaints reaching a 5-year high, and the cost to consumers increasing, the longer the fraud goes undetected, according to Javelin Strategy & Research, the urgency to guard against this crime has increased as well.
A team of scientists from I.M. Sechenov First Moscow State Medical University together with their colleagues isolated a peptide named emericellipsin A from soil fungi.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
› Verified 8 days ago
Others | 31 |
Total Volunteers | 31 |
---|
News Archive
Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.
With identity theft complaints reaching a 5-year high, and the cost to consumers increasing, the longer the fraud goes undetected, according to Javelin Strategy & Research, the urgency to guard against this crime has increased as well.
A team of scientists from I.M. Sechenov First Moscow State Medical University together with their colleagues isolated a peptide named emericellipsin A from soil fungi.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
› Verified 8 days ago
Hospice Of Mercy-durango Location: 175 Mercado Street, Suite 131, Durango, Colorado, 81301 Phone: (970) 382-2000 |